Related Experiment Video
Updated: May 30, 2026
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Key role of the molecular autopsy in sudden unexpected death
Christopher Semsarian1, Robert M Hamilton
1Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia. c.semsarian@centenary.org.au
Insights
Sudden Cardiac Death (SCD) in young individuals is often due to genetic disorders. Genetic testing and molecular autopsy are crucial for diagnosing inherited conditions and preventing future deaths in at-risk families.
Area of Science:
- Cardiology
- Genetics
- Forensic Medicine
Background:
- Sudden Cardiac Death (SCD) is a significant cause of mortality, particularly in younger populations.
- Unlike older adults, SCD in individuals under 40 is frequently linked to genetic disorders like inherited cardiomyopathies and primary arrhythmogenic diseases.
Purpose of the Study:
- To highlight the evolving role of genetic testing in evaluating families with SCD.
- To emphasize the importance of molecular autopsy in identifying causes of Sudden Unexpected Death (SUD) when conventional postmortem examination is inconclusive.
Main Methods:
- Clinical evaluation of families experiencing SCD.
- Genetic testing to identify underlying inherited cardiovascular conditions.
- Molecular autopsy for cases of SUD to determine the cause of death.
Main Results:
- Genetic testing is instrumental in diagnosing inherited cardiomyopathies and arrhythmogenic diseases.
- Molecular autopsy provides crucial etiological information in unexplained SUD cases.
- Combined clinical and genetic evaluation facilitates targeted interventions.
Conclusions:
- Genetic testing and molecular autopsy are essential tools in the investigation of SCD in the young.
- Early diagnosis and risk stratification of families affected by SCD can lead to preventative strategies.
- Integrating genetic insights into clinical practice aims to reduce SCD incidence in the community.
Abstract:
Sudden Cardiac Death (SCD) is a major and tragic complication of a number of cardiovascular diseases. While in the older populations, SCD is most frequently caused by underlying coronary artery disease and heart failure, in those aged under 40 years, the causes of SCD commonly include genetic disorders, such as inherited cardiomyopathies and primary arrhythmogenic diseases. As part of the evaluation of families in which SCD has occurred, the role of genetic testing has evolved as an important feature in both establishing an underlying diagnosis and in screening at-risk family relatives. Specifically, in cases where no definitive cause is identified at postmortem, i.e. Sudden Unexpected Death (SUD), the "molecular autopsy" has emerged as a key process in the investigation of the cause of death. The combination of clinical and genetic evaluation of families in which SUD has occurred provides a platform for early initiation of therapeutic and prevention strategies, with the ultimate goal to reduce sudden death among the young in our communities.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...